Biostar Pharmaceuticals 

$0
2
+$0+0% Wednesday 21:00

統計

當日最高
0
當日最低
0
52週高點
0
52週低點
0
成交量
150
平均成交量
100
市值
263.7
本益比
0
股息殖利率
-
股息
-

財報

18Nov預期
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
預期EPS
0
實際EPS
0

財務

-239.01%利潤率
未盈利
2011
2012
2013
2014
2015
2016
4.77M營收
-11.4M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 BSPM 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Show more...
執行長
Mr. Ronghua Wang Ph.D.
員工
200
國家
US
ISIN
US0906783016

上市

0 Comments

分享你的想法

FAQ

Biostar Pharmaceuticals 今天的股價是多少?
BSPM 目前價格為 $0 USD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Biostar Pharmaceuticals 股價表現。
Biostar Pharmaceuticals 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Biostar Pharmaceuticals 的股票以代號 BSPM 進行交易。
Biostar Pharmaceuticals 的市值是多少?
今天 Biostar Pharmaceuticals 的市值為 263.7
Biostar Pharmaceuticals 上一季度的財報如何?
BSPM 上一季度的財報為每股 0 USD,預估為 0 USD,帶來 +NaN% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Biostar Pharmaceuticals 去年的營收是多少?
Biostar Pharmaceuticals 去年的營收為 4.77MUSD。
Biostar Pharmaceuticals 去年的淨利是多少?
BSPM 去年的淨收益為 -11.4MUSD。
Biostar Pharmaceuticals 有多少名員工?
截至 April 01, 2026,公司共有 200 名員工。
Biostar Pharmaceuticals 位於哪個產業?
Biostar Pharmaceuticals從事於Health Care產業。
Biostar Pharmaceuticals 何時完成拆股?
Biostar Pharmaceuticals 上次拆股發生於 February 05, 2016,比例為 1:7。
Biostar Pharmaceuticals 的總部在哪裡?
Biostar Pharmaceuticals 的總部位於 US 的 Xianyang。